Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

Autor: Hwang ES; Department of Surgery, Duke University, Durham, North Carolina., Hyslop T; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Lynch T; Department of Surgery, Duke University, Durham, North Carolina., Ryser MD; Departments of Population Health Sciences and Mathematics, Duke University, Durham, North Carolina., Weiss A; Department of Surgery/Oncology, University of Rochester, Rochester, New York., Wolf A; Alliance Foundation Trials, Boston, Massachusetts., Norris K; Alliance Foundation Trials, Boston, Massachusetts., Witten M; Aurora Health Care, Milwaukee, Wisconsin., Grimm L; Department of Radiology, Duke University, Durham, North Carolina., Schnitt S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Badve S; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia., Factor R; Department of Pathology, Duke University, Durham, North Carolina., Frank E; COMET Study Patient Leadership Team, Alliance Foundation Trials, Boston, Massachusetts., Collyar D; COMET Study Patient Leadership Team, Alliance Foundation Trials, Boston, Massachusetts., Basila D; COMET Study Patient Leadership Team, Alliance Foundation Trials, Boston, Massachusetts., Pinto D; COMET Study Patient Leadership Team, Alliance Foundation Trials, Boston, Massachusetts., Watson MA; Department of Pathology and Immunology, Washington University in St Louis, St Louis, Missouri., West R; Department of Pathology, Stanford University, Stanford, California., Davies L; The VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction Vermont and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire., Donovan JL; Population Health Sciences, University of Bristol, Bristol, United Kingdom., Shimada A; Division of Biostatistics/Bioinformatics, Thomas Jefferson University, Philadelphia, Pennsylvania., Li Y; Division of Biostatistics/Bioinformatics, Thomas Jefferson University, Philadelphia, Pennsylvania., Li Y; Duke Cancer Institute Biostatistics Shared Resource, Duke University, Durham, North Carolina., Bennett AV; Department of Health Policy and Management, University of North Carolina at Chapel Hill., Rosenberg S; Division of Epidemiology, Weill Cornell University, New York, New York., Marks J; Department of Surgery, Duke University, Durham, North Carolina., Winer E; School of Medicine, Yale University, New Haven, Connecticut., Boisvert M; Division of Breast Surgery, Medstar Washington Hospital Center, Washington, DC., Giuliano A; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California., Larson KE; Department of Surgery, The University of Kansas Health System, Kansas City., Yost K; Cancer Research Consortium of West Michigan NCORP, Grand Rapids., McAuliffe PF; Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Krie A; Metro MN Community Oncology Research Consortium, St Louis Park, Minnesota., Tamirisa N; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston., Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill., Thompson AM; Department of Surgery, Baylor College of Medicine, Houston, Texas., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publikováno v: JAMA [JAMA] 2024 Dec 12. Date of Electronic Publication: 2024 Dec 12.

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.

Autor: Sharma P; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City., Yoder R; The University of Kansas Cancer Center, Kansas City., Staley JM; The University of Kansas Cancer Center, Kansas City., Schwensen K; Department of Internal Medicine, University of Kansas Medical Center, Westwood., O'Dea A; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Nye L; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Satelli D; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Crane G; Department of Internal Medicine, University of Kansas Medical Center, Westwood., Madan R; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City., O'Neil MF; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City., Wagner J; Department of Surgery, University of Kansas Medical Center, Kansas City., Larson KE; Department of Surgery, University of Kansas Medical Center, Kansas City., Balanoff C; Department of Surgery, University of Kansas Medical Center, Kansas City., Kilgore L; Department of Surgery, University of Kansas Medical Center, Kansas City., Phadnis MA; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City., Godwin AK; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.; The University of Kansas Cancer Center, Kansas City., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter Mac Callum Canter Centre, Melbourne, Australia., Khan QJ; Department of Internal Medicine, University of Kansas Medical Center, Westwood., O'Shaughnessy J; Baylor University Medical Center, Dallas, Texas.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Feb 01; Vol. 10 (2), pp. 227-235.

Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.

Autor: Boughey JC; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA. boughey.judy@mayo.edu., Yu H; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Dugan CL; Breast Care Center, UCSF Health, San Francisco, CA, USA., Piltin MA; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Postlewait L; Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA., Son JD; Ourisman Breast Center, MedStar Georgetown University, Washington, DC, USA., Edmiston KK; Department of Surgery, University of Virginia, Inova Campus, Fairfax, VA, USA., Godellas CV; Department of Surgery, Loyola University Medical Center, Maywood, IL, USA., Lee MC; Division of Breast Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Carr MJ; Department of Breast Surgery, Moffitt Cancer Center, Tampa, FL, USA., Tonneson JE; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA., Crown A; True Family Women's Cancer Center, Swedish Cancer Institute, Seattle, WA, USA., Lancaster RB; Division of Surgical Oncology, The University of Alabama at Birmingham Medical Center, Birmingham, AL, USA., Woriax HE; Division of Surgical Oncology, Duke University of School of Medicine, Durham, NC, USA., Ewing CA; Division of Surgical Oncology, University of California, San Francisco, CA, USA., Chau HS; Department of Surgery, UC San Diego, La Jolla, CA, USA., Patterson AK; Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA., Wong JM; Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA., Alvarado MD; Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA., Yang RL; Department of Surgery, Stanford Hospital and Clinics, Stanford, CA, USA., Chan TW; Department of Breast Surgical Oncology, Ironwood Cancer and Research Centers, Scottsdale, AZ, USA., Sheade JB; Division of Hematology and Oncology, University of Chicago, Chicago, IL, USA., Ahrendt GM; Division of Surgical Oncology, University of Colorado Denver - Anschutz Medical Campus, Boulder, CO, USA., Larson KE; Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Switalla K; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Tuttle TM; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Tchou JC; Department of Breast Surgery Research, Penn Medicine at University of Pennsylvania, Philadelphia, PA, USA., Rao R; Division of Breast Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA., Tamirisa N; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Singh P; Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gould RE; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Terando A; Division of Surgical Oncology, Department of Surgery, Huntington Cancer Center/Cedars Sinai Cancer, Pasadena, CA, USA., Sauder C; Department of Surgery, UC Davis Health Comprehensive Cancer Center, Sacramento, CA, USA., Hewitt K; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Chiba A; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Esserman LJ; Departments of Surgery and Radiology, UCSF, San Francisco, CA, USA., Mukhtar RA; Department of Surgery, UCSF, San Francisco, CA, USA.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2023 Oct; Vol. 30 (11), pp. 6401-6410. Date of Electronic Publication: 2023 Jun 28.